PSI CRO, 23 July 2024 – PSI CRO continues to invest in its operational capabilities across the globe with the relocation to a new Serbia office at Džona Kenedija 31b, 11 070, Novi Beograd, Belgrade. Since opening its first Serbia office in 2008, PSI has been steadfast in its commitment to furthering the region’s vibrant life sciences community. The three-times-larger premises will accommodate PSI’s growing team and allow for greater collaboration to support sponsors of pivotal trials.
The new office is situated in the vibrant New Belgrade administrative and business center, overlooking the river Danube. With features such as a gym for stretching after a long day and a rooftop terrace with a panoramic view of the city, the space will serve as a central location for PSI’s continued growth in the region.
“This was all made possible by the people behind this unique company,” said Country Manager Mirjana Jovanovic. “We never lose focus of our goal of achieving predictable, reliable patient enrollment. It’s hard work, and everyone has a role to play. This new space provides the ideal location for our dedicated Belgrade team to come together for our sponsors.”
To learn more about the new Belgrade office or PSI’s full-service CRO capabilities, connect with us here.
About PSI: PSI CRO is a privately-owned, full-service clinical research organization (CRO) operating globally. PSI’s global reach supports clinical trials across multiple countries and continents and specializes in the planning and execution of global pivotal registration clinical trials. With an exceptionally high repeat and referral business rate combined with minimal staff turnover, PSI is committed to being the best CRO in the world as measured by its employees, customers, investigators, and vendors.
Global headquarters are located in Switzerland at 113a Baarerstrasse, Zug 6300. www.psi-cro.com
For Media Inquiries
Paul Mirek
